Therapy-related acute promyelocytic leukemia (t-APL) has been increasingly reported after exposure to cytotoxic and/or immunosuppressive agents given for prior malignancies or autoimmune diseases. t-APL represents both a model for better understanding human leukemogenesis and an interesting therapeutic subset which requires specific adaptations for optimal management.
LO COCO, F., Hasan, S., Montesinos, P., Sanz, M. (2013). Biology and management of therapy-related acute promyelocytic leukemia. CURRENT OPINION IN ONCOLOGY, 25(6), 695-700 [10.1097/CCO.0000000000000013].
Biology and management of therapy-related acute promyelocytic leukemia
LO COCO, FRANCESCO;
2013-01-01
Abstract
Therapy-related acute promyelocytic leukemia (t-APL) has been increasingly reported after exposure to cytotoxic and/or immunosuppressive agents given for prior malignancies or autoimmune diseases. t-APL represents both a model for better understanding human leukemogenesis and an interesting therapeutic subset which requires specific adaptations for optimal management.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
